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Protein tunnels, channels and gates are important for enzymatic catalysis and also represent attractive targets 
for rational protein design and drug design [1]. Drug molecules blocking the access of natural substrate or 
release of products are very efficient modulators of biological activity. Here we demonstrate the application of 
newly in-house developed software tool CaverDock [2,3] for the analysis of the transport of ligands through 
tunnels in biomolecular targets. Caverdock is a new addition to the Caver Suite [4-6]. We performed virtual 
screening of large databases of drugs against two pharmacologically relevant targets. We have used FDA-
approved drugs for both targets. Oncological drugs (133 molecules), taken from the NIH website, and anti-
inflammatory (56 molecules), taken from the Drugbank website, as the libraries of ligands for the two molecular 
targets: (i) cytochrome P450 17A1 and (ii) leukotriene A4 hydrolase/aminopeptidase. Moreover, we will also 
show the unbinding of the 2,3-dichloropropan-1-ol product from a buried active site of an haloalkane 
dehalogenase and its variant. With this study we identified hot-spots that may be used for directed evolution or 
site-directed mutagenesis to create new variants for faster 2,3-dichloropropan-1-ol release [7]. Finally, we will 
show the difference on ligand transportation when a protein is in an open and closed conformations [8]. We will 
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